Latest Cash Flow News

Deep Yellow Limited reported a $10.6 million operating cash outflow for the September quarter but maintains a robust cash position with over $203 million on hand, supporting an estimated 14 quarters of funding.

Meeka Metals delivered a strong September quarter with gold production exceeding feasibility study forecasts and costs coming in below plan, underpinning confidence in the Murchison Gold Project’s growth trajectory.

Meeka Metals reported a robust cash position of A$34 million at the end of September 2025, despite heavy investment in project development and exploration activities during the quarter.

Regis Resources reported a solid September quarter with 90.4koz gold production and a $158 million increase in cash and bullion. Key underground projects at Garden Well Main and Rosemont Stage 3 began ore production, supporting steady FY26 guidance.

Australis Oil & Gas reported a modest dip in production volumes for Q3 2025 but offset this with higher realised oil prices and disciplined cost management. The company remains focused on securing a development partner to unlock the full potential of its Tuscaloosa Marine Shale assets.

Sigma Healthcare’s transformative merger with Chemist Warehouse has propelled the company into Australia’s top 20 ASX firms, with FY25 results exceeding expectations and synergy targets nearly doubling.

Cokal Limited’s PT Bumi Barito Mineral has resumed limited mining operations and appointed PT Harapan Mitra Lestari as its mining contractor, while upgrading logistics infrastructure to support future production growth.

Winchester Energy has successfully completed drilling the JVU-5 well at its Varn waterflood project in Texas, confirming promising oil and gas shows and setting the stage for production ramp-up.

Aeris Resources reported solid Q1 FY26 results with steady copper and gold production, disciplined cost management, and advancing divestment plans for non-core assets.

Aeris Resources reported steady Q1 FY26 production with 10.3kt copper equivalent at AISC of A$4.64/lb, alongside significant growth capital investment and promising exploration results.

Vitasora Health has received $2.43 million from a cornerstone investor, advancing its $11 million capital raise and reinforcing its path to profitability by Q4 FY2026. The company’s expanding US partnerships and technology investments signal growing market confidence.

Imricor Medical Systems made significant regulatory strides with FDA submissions for its MRI-guided cardiac ablation devices and launched NorthStar commercially in Europe, even as it reported increased cash outflows in Q3 CY25.